Can I Sell Peptides in the UK? What the Law Actually Requires

Can I sell peptides in the UK?

Yes and no, depending entirely on what you are selling and how you describe it. The peptide itself — a short chain of amino acids — is not a controlled or banned substance simply by virtue of being a peptide. What determines legality is a separate question: does the product, as sold, count as a "medicinal product" under the Human Medicines Regulations 2012 (SI 2012/1916)? If it does, selling it requires a Marketing Authorisation and the relevant manufacturing or wholesale licensing from the Medicines and Healthcare products Regulatory Agency (MHRA). If it genuinely does not — because it is sold to a laboratory or research buyer with no implied human use — a different, lighter set of obligations applies, built around general product safety and consumer protection law rather than medicines licensing.

This is the point most sellers get wrong. They assume that avoiding the word "medicine," adding a "not for human consumption" disclaimer, or calling a product "research grade" is enough to place it outside the regulatory perimeter. It is not. The MHRA does not classify products by their label alone.

What decides whether a peptide is treated as a medicine under UK law?

The Human Medicines Regulations 2012 define a medicinal product using two independent tests, and a product only needs to fail one of them to be caught. The first is the presentation test: is the product presented as having properties for treating or preventing disease, or otherwise presented as something to be administered to restore, correct, or modify a physiological function? Presentation is read broadly — it covers packaging, website copy, social media posts, influencer partnerships, customer reviews the seller amplifies, and even the images used alongside a listing. A peptide sold next to language about fat loss, muscle recovery, skin ageing, or libido is presented as a medicine, whatever the small print says.

The second is the function test: does the product actually have a pharmacological, immunological, or metabolic action capable of restoring, correcting, or modifying a physiological function when used by humans? A peptide can fail this test even with entirely neutral marketing, if the objective evidence shows it functions that way and is realistically going to be used that way by the buyer. The two tests exist precisely to close the loophole of relabelling a therapeutic product as something innocuous. Full statutory text is published by the UK government at legislation.gov.uk/uksi/2012/1916.

Do I need an MHRA licence to sell peptides?

If the product is caught by either test above, then yes — and the licensing stack is not a single document. Selling a medicinal product in the UK generally requires: a Marketing Authorisation for that specific product (proving safety, quality, and efficacy to MHRA standards); a Manufacturer's Licence if you produce or repackage it; and a Wholesale Dealer's Licence to distribute a licensed medicine onward to pharmacies, clinics, or other wholesalers. None of these are granted informally, and none can be substituted with a supplier's own certificate of analysis, however legitimate that document is for confirming the chemical content of a batch. A CoA answers "what is in this vial"; it says nothing about "is this vial legally authorised to be sold as a medicine in the UK," which is a separate MHRA determination. Current guidance and the licensing application process are published by the agency at gov.uk/MHRA.

If the product genuinely sits outside medicines regulation — sold without health claims to research or laboratory customers — a Marketing Authorisation is not required. But the seller is not then operating in an unregulated space. The General Product Safety Regulations 2005 impose a general duty to place only safe products on the market, with obligations around labelling, traceability, and withdrawal of unsafe batches; the full text sits at legislation.gov.uk/uksi/2005/1803.

Selling scenarios: which are lawful and which are not

The same peptide can sit in four different legal positions depending entirely on how it is sold. The chemistry never changes; the classification does.

What happens if I add health claims to a peptide listing?

A health claim converts the product into a medicine by presentation, but it also opens a second, independent line of liability that many sellers overlook because they are focused only on the MHRA. The Consumer Protection from Unfair Trading Regulations 2008 prohibit misleading commercial practices, and a claim that a product treats, prevents, or otherwise affects a medical condition without supporting authorisation is treated as misleading by definition, not as a matter of opinion. Trading Standards, which enforces consumer protection law at local authority level, can act on this regardless of whether the MHRA has separately opened an investigation into the medicines question.

Advertising carries its own layer again. The Advertising Standards Authority's CAP Code, Section 12, specifically restricts marketing communications for medicines, medical devices, and health-related products, and applies to organic social posts and paid ads alike. An ASA ruling against a seller is public, searchable, and typically requires the ad to be withdrawn — a reputational and commercial cost that lands well before any criminal referral.

Do marketplace and advertising rules add another layer?

Yes, and they are frequently faster and more consistently enforced than the underlying medicines law. Amazon, eBay, Etsy, and similar UK-facing marketplaces prohibit unlicensed medicinal claims in their own seller policies, and typically remove listings or suspend accounts on an internal review basis, without waiting for a regulator to act. Google Ads and Meta's advertising policies restrict health claims for uncertified products even more tightly, often blocking an ad at the review stage before it ever runs. A seller who never hears from the MHRA can still lose their entire distribution channel through a platform-level policy breach, which makes platform compliance a practical filter that sits in front of, not behind, the legal one.

Do I need to register as a business or charge VAT?

Yes, and this obligation exists entirely independently of the medicines question above — it applies to any UK trading activity. Selling peptides, licensed or not, is a business activity that must be registered with HMRC, whether as a sole trader, partnership, or limited company through Companies House. VAT registration becomes mandatory once taxable turnover crosses the threshold HMRC sets and periodically reviews (£90,000 as of the 2024–25 tax year; sellers should confirm the current figure directly with HMRC, as thresholds are subject to change at each Budget). There is no separate or reduced tax regime for peptide sales, and no exemption tied to a "research use only" framing — HMRC's registration requirements track the trading activity, not the product's medicines classification.

What are the penalties for getting this wrong?

Selling an unlicensed medicinal product in the UK is a criminal offence under the Human Medicines Regulations 2012, not a civil or administrative matter. Penalties on conviction can include an unlimited fine and a custodial sentence, and the MHRA's Criminal Enforcement Unit has statutory powers to seize stock, freeze listings, and prosecute, working alongside Trading Standards and, where imports are involved, Border Force. Separately, an adverse ASA ruling or a Trading Standards enforcement notice under the Consumer Protection from Unfair Trading Regulations 2008 can shut down the commercial side of the business well before any criminal case concludes. The three enforcement tracks — medicines law, consumer protection law, and advertising self-regulation — operate independently, which means a seller can be caught by any one of them even if they believe they have satisfied the others.

Summary: the direct answer

You can sell peptides in the UK if the product is genuinely outside medicines regulation — sold with no health claim, to a real research or laboratory buyer — while still meeting general product safety, business registration, and VAT obligations. You cannot sell a peptide as, or presented as, a human health product without a Marketing Authorisation and the matching MHRA licence, and adding a "research use only" disclaimer does not change that outcome if the marketing around it implies human therapeutic use. The classification turns on presentation and function, not on the word printed on the label, and the enforcement risk runs across MHRA criminal law, Trading Standards consumer protection powers, and independent advertising and marketplace policy — any one of which can act alone.